This modulation may actually enhance certain aspects of immune function, especially in individuals with obesity who often experience immune dysregulation with chronic low-grade inflammation
For adherent SC-islets, SC-islets were first dissociated with 0.25% trypsin and seeded onto 33-mm confocal dishes (Beyotime, #FCFC020-150pcs) coated with Matrigel diluted to 1:3
The study, which was led by Joseph Rizzo, MD, director of the Neuro-Ophthalmology Service at Mass Eye and Ear and the Simmons Lessell Professor of Ophthalmology at Harvard Medical School, published July 3rd in JAMA Ophthalmology
In a randomized trial using PET-MRI to assess carotid plaque inflammation, semaglutide did not show a significant difference versus placebo on the prespecified primary plaque-inflammation endpointslikely influenced by low baseline inflammatory burden in a well-treated population. How to interpret this: Imaging studies like this are helpful for understanding mechanisms and terminology (e.g., atherosclerotic inflammation, PET-MRI plaque imaging), but they do not establish semaglutide as a direct vascular inflammation imaging reducer in general clinical use based on current evidence. 5) They Improve Kidney Outcomes in High-Risk Populations (Semaglutide) By improving glycemic control and metabolic stress, GLP-1 therapies can reduce kidney risk in susceptible patients
This is precisely what makes the intersection with eating disorders so complicated
